Followers | 101 |
Posts | 13186 |
Boards Moderated | 0 |
Alias Born | 06/01/2013 |
Sunday, February 28, 2021 12:53:06 PM
https://www.ivi.unibe.ch/research/immunology/group_benarafa/projects/index_eng.html
David E. Wentworth’s laboratory
Daniel B. Jernigan, M.D., M.P.H., is the director of the Influenza Division in CDC’s National Center for Immunization and Respiratory Diseases (NCIRD)
Dr. Jernigan received an undergraduate degree from Duke University, a Doctor of Medicine from Baylor College of Medicine, and a Master of Public Health from the University of Texas.
David Wentworth, Ph.D
https://www.cdc.gov/ncird/div/flu/flu-bios.html
Joseph Bresee, M.D., is Influenza Division’s associate director of global health affairs. Dr. Bresee also serves as director of the Partnership for Influenza Vaccine Introduction, based at the Task Force for Global Health, which seeks to accelerate the use of influenza vaccines in low and middle-income countries through public-private partnerships. He is the director of the Global Funders Consortium for Universal Influenza Vaccine Development, which provides a mechanism for global funders and stakeholders involved in next generation vaccine development to share strategies and lesson to accelerate progress in the field.
Dr. Bresee trained at Baylor College of Medicine in Houston, and then completed his Pediatric Residency at Children’s Hospital and Medical Center at the University of Washington in Seattle. Dr. Bresee joined CDC in 1993 as an Epidemic Intelligence Service (EIS) officer in the Influenza Branch. From 1995 to 2005, Dr. Bresee first served as a staff epidemiologist and medical officer, specializing in viral gastrointestinal infections and respiratory infections. He was chief of CDC Influenza Division’s Epidemiology and Prevention Branch from 2005-2017, overseeing a broad portfolio of global and domestic surveillance, research and policy activities for the Influenza Division. Dr. Bresee served as an officer in the U.S. Public Health Service. He retired as a Captain in 2017, after 24 years in the Commissioned Corps.
Recent MYMX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM